Aquatic Capital Management LLC Buys New Shares in Astera Labs, Inc. $ALAB

Aquatic Capital Management LLC purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 57,757 shares of the company’s stock, valued at approximately $11,309,000.

Other large investors also recently modified their holdings of the company. Assetmark Inc. raised its holdings in Astera Labs by 374.1% during the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after acquiring an additional 101 shares in the last quarter. Pinpoint Asset Management Singapore Pte. Ltd. bought a new position in Astera Labs in the third quarter valued at approximately $47,000. Whittier Trust Co. bought a new position in Astera Labs in the third quarter valued at approximately $55,000. Ramirez Asset Management Inc. acquired a new position in shares of Astera Labs during the 3rd quarter worth approximately $59,000. Finally, Atlantic Union Bankshares Corp increased its position in shares of Astera Labs by 1,338.1% during the 3rd quarter. Atlantic Union Bankshares Corp now owns 302 shares of the company’s stock worth $59,000 after purchasing an additional 281 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on ALAB shares. Northland Securities increased their price objective on Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a report on Tuesday, December 9th. BNP Paribas Exane began coverage on shares of Astera Labs in a report on Thursday, November 20th. They set an “outperform” rating on the stock. Royal Bank Of Canada started coverage on shares of Astera Labs in a research report on Wednesday, January 14th. They set an “outperform” rating and a $225.00 price target on the stock. Loop Capital assumed coverage on shares of Astera Labs in a research note on Thursday, March 5th. They issued a “buy” rating and a $250.00 price target for the company. Finally, Jefferies Financial Group reissued a “buy” rating on shares of Astera Labs in a research report on Wednesday, December 3rd. Fifteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $202.22.

Astera Labs Stock Up 0.3%

ALAB opened at $120.31 on Monday. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90. The stock has a market cap of $20.48 billion, a price-to-earnings ratio of 98.61, a PEG ratio of 2.37 and a beta of 1.75. The business has a 50 day moving average of $147.89 and a 200-day moving average of $168.03.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping the consensus estimate of $0.51 by $0.07. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The company had revenue of $270.58 million during the quarter, compared to the consensus estimate of $249.46 million. During the same period in the previous year, the company posted $0.37 EPS. The firm’s revenue for the quarter was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Insider Activity

In other news, General Counsel Philip Mazzara sold 10,000 shares of the firm’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $117.47, for a total transaction of $1,174,700.00. Following the completion of the sale, the general counsel owned 128,084 shares in the company, valued at approximately $15,046,027.48. This trade represents a 7.24% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Jitendra Mohan sold 94,971 shares of the firm’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the sale, the chief executive officer owned 1,452,739 shares of the company’s stock, valued at approximately $179,863,615.59. This represents a 6.14% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 224,292 shares of company stock valued at $27,676,069. 12.50% of the stock is owned by company insiders.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.